Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kangaroo OMNI™ Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey. Kangaroo OMNI™ is the…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review a new Biologics License Application (BLA) for sotatercept, Merck’s novel investigational activin…
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced a series of activities promoting the importance of breast cancer screenings throughout Breast Cancer Awareness Month, including a global partnership with Know Your Lemons, a nonprofit organization committed…
The “US Medical Device Cleaning & Recycling Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. In the US, the medical device cleaning & recycling market was valued at $3.52 billion in 2022 and is expected to grow at a CAGR…
AscellaHealth has ranked second on the Philadelphia Business Journal’s 2023 “Soaring 76” list of fastest-growing companies in Greater Philadelphia and first for fastest-growing private company, as measured by revenue over a three-year period from 2020 through 2022. This is the Company’s fourth time…
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, announced its presence at the AHCA/NCAL Convention & Expo: Delivering Solutions 23. The company will join the long-term…
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on September 29, 2023. Four individuals were hired by Adicet in September 2023.…
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan,…
CVS Health® Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the “Board”) of CVS Health, effective November 1. “Mike’s focus…
Pfizer Inc. (NYSE: PFE) shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) following a favorable vote for ABRYSVO™ [Respiratory Syncytial Virus…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today provided updates on two Phase 3 trials, LEAP-006 and LEAP-008, evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-A39 trial (also known as EV-302), which was conducted in collaboration with Seagen and Astellas, evaluating KEYTRUDA, Merck’s…